Mesalazine Effects in Sporadic Colorectal Adenoma Patients

NCT01894685 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

74

Enrollment

OTHER

Sponsor class

Conditions

Sporadic Colorectal Adenoma

Interventions

DRUG: Mesalazine
DRUG: Placebo

Sponsor

UMC Utrecht